ORGALUTRAN 0.25MG/0.5ML (SOLUTION FOR INJECTION)

Manufacturer
Vetter Pharma-Fertigung, GmbH & Co.KG(GERMANY)

Registraction Number
MAL20034576ACRZ

Content:
Each syringe contains 0.25 mg of ganirelix as the active ingredient.
Indication:
Orgalutran is used to prevent premature ovulation in women undergoing assisted reproduction techniques, such as in vitro fertilization (IVF). It works by inhibiting the action of gonadotrophin-releasing hormone (GnRH), which helps to suppress the release of luteinizing hormone (LH) and prevent early ovulation.
Instructions:

• Dosage: Administer 0.25 mg (one syringe) subcutaneously once a day. Treatment typically starts on day 5 or 6 after the beginning of ovarian stimulation with follicle-stimulating hormone (FSH) or corifollitropin alfa.
• Administration: Inject into the upper leg. The patient or their partner may administer the injection if they have been trained and have access to expert advice.
• Precautions: Do not use if you are allergic to ganirelix or any of the other ingredients. Inform your doctor if you have moderate or severe kidney or liver disease, or if you are pregnant or breastfeeding.